1. 1ISG-001 Health utilities in chronic hepatitis C patients one year after successful treatment with direct-acting antivirals. (March 2019) Authors: Juanbeltz, R; Goñi-Esarte, S; Martínez-Baz, I; San Miguel, R; Zozaya, JM; Rivero, M; Herrero, I; Larrayoz, B; Sarobe, M; Castilla, J Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1ISG-037 Health-related quality of life in hepatitis c patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population. (March 2019) Authors: Juanbeltz, R; Castilla, J; Martínez-Baz, I; O'Leary, A; Burgui, C; Preciado, J; Ulacia, L; Larrayoz, B; Sarobe, M; San Miguel, R Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-088 Effectiveness of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C. (March 2019) Authors: Burgui, C; Juanbeltz, R; Castilla, J; Larrayoz, B; Sarobe, M; Zozaya, JM; Gracia-Ruiz de Alda, M; San Miguel, R Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 4CPS-089 Retreatment of patients with hepatitis C virus infection after virological failure to direct-acting antivirals. (March 2019) Authors: Burgui, C; Juanbeltz, R; Castilla, J; Larrayoz, B; Sarobe, M; Perez, A; Aguinaga, A; Zozaya, Jm; Gracia-Ruiz de Alda, M; San Miguel, R Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5PSQ-012 Are 12 months of treatment with monoclonal antibodies sufficient for migraine attack prevention?. (23rd March 2022) Authors: Fresan, D; Lacalle, E; Calvo, M; Tejada, D; Albalat Torres, A; Ortega, I; Pino, A; Erdozain, S; Larrayoz, B; Sarobe, M Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗